No Data
No Data
Gene-sequencing Group Illumina Sees $1.47 Bn Q2 Impairment Charge Linked to Grail
Express News | Illumina will make a $1.47 billion goodwill write-down related to Grail in Q2.
Illumina to Take $1.47 Billion Goodwill Impairment Charge Related to Grail in Q2
Express News | Grail Inc - Estimates That It Will Recognize a Goodwill Impairment Charge in Q2 of 2024 Equal to $888.9 Mln
Express News | Illumina Inc - Estimates That It Will Recognize an Impairment Charge for Grail Ipr&D Intangible Asset in Q2 of 2024 Equal to $420 Mln
Express News | Summit Therapeutics Appoints Jeff Huber, Transformational Google and Grail Executive, to Its Board of Directors